"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

Baxalta, Precision BioSciences Partner in Up-to-$1.7B Immuno-Oncology Collaboration

DURHAM, N.C. – Baxalta and Precision BioSciences said today they will partner to develop allogeneic chimeric antigen receptor T cell (CAR-T) therapies, in a collaboration that could generate up to $1.7 billion for Precision.

read more

Apellis Completes $47 Million Series D Financing

Louisville, KY-based Apellis Pharmaceuticals, Inc., announced on February 12th, that it has completed a $47.1 million Series D preferred stock .

read more

UNC gene therapy spinout Bamboo Therapeutics raises $49.5M Series A

CHAPEL HILL, N.C. – North Carolina gene therapy startup Bamboo Therapeutics has raised a stunning $49.5 million, according to an SEC filing. The startup is focused on advancing the work of Dr. Richard Jude Samulski, director of the gene therapy center at the University of North Carolina, into the clinic to treat rare neurologic diseases like Duchenne’s muscular dystrophy.

read more